Condor Capital Management Increased Its Holding in Scotts Miracle Gro Co (SMG) by $1.08 Million; Amgen (AMGN) Market Value Declined While Founders Financial Securities Has Raised by $379,780 Its Holding

July 12, 2018 - By Joe Cepeda

Amgen Inc. (NASDAQ:AMGN) Logo

Condor Capital Management increased its stake in Scotts Miracle Gro Co (SMG) by 191.5% based on its latest 2018Q1 regulatory filing with the SEC. Condor Capital Management bought 12,704 shares as the company’s stock declined 6.44% with the market. The institutional investor held 19,338 shares of the agricultural chemicals company at the end of 2018Q1, valued at $1.66M, up from 6,634 at the end of the previous reported quarter. Condor Capital Management who had been investing in Scotts Miracle Gro Co for a number of months, seems to be bullish on the $4.78B market cap company. The stock decreased 1.22% or $1.07 during the last trading session, reaching $86.31. About 264,677 shares traded. The Scotts Miracle-Gro Company (NYSE:SMG) has declined 3.29% since July 12, 2017 and is downtrending. It has underperformed by 15.86% the S&P500. Some Historical SMG News: 17/04/2018 – SCOTTSMIRACLE-GRO TO BUY SUNLIGHT SUPPLY INC., MARKING MAJOR; 23/05/2018 – Moody’s Confirms Scotts Miracle-Gro Ba2 Cfr; Outlook Is Stable; 18/04/2018 – MOODY’S REVIEWS SCOTTS MIRACLE GRO FOR DOWNGRADE; 01/05/2018 – SCOTTS MIRACLE-GRO CONFERENCE CALL CONCLUDES; 01/05/2018 – SCOTTS MIRACLE-GRO 2Q ADJ EPS $2.88, EST. $3.31; 18/04/2018 – S&PGRBulletin: Scotts Miracle-Gro Rtgs Unaffctd By Acqstn; 17/04/2018 – SCOTTS MIRACLE-GRO – BENEFITS FROM TRANSACTION ARE EXPECTED TO IMPROVE YEAR-OVER-YEAR NON-GAAP ADJUSTED EARNINGS BY $0.60 TO $0.80 PER SHARE IN FY 2019; 17/04/2018 – Scotts Miracle-Gro Buys Sunlight to Double Cannabis-Grower Sales; 18/04/2018 – Scotts® Introduces New Smart Devices and Precision Watering Systems to Help Conserve Water; 03/05/2018 – Scotts Miracle-Gro Names David C. Evans to Board

Founders Financial Securities Llc increased its stake in Amgen Inc (AMGN) by 61.53% based on its latest 2018Q1 regulatory filing with the SEC. Founders Financial Securities Llc bought 2,234 shares as the company’s stock declined 5.44% with the market. The institutional investor held 5,865 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $1.00M, up from 3,631 at the end of the previous reported quarter. Founders Financial Securities Llc who had been investing in Amgen Inc for a number of months, seems to be bullish on the $127.81B market cap company. The stock decreased 1.30% or $2.54 during the last trading session, reaching $193.15. About 1.69 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since July 12, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 01/05/2018 – Regeneron Pharma: Agreement Provides Praluent at Lower Net Price and Enables Streamlined Patient Access Based on Physician Attestatio; 17/04/2018 – AMGEN AMGN.O TRIAL SHOWED EPISODIC MIGRAINE FREQUENCY CUT BY AT LEAST 50 PERCENT IN 30.3 PERCENT OF AIMOVIG PATIENTS VS 13.7 PERCENT OF PLACEBO GROUP; 21/05/2018 – AMGEN: FDA OKS PROLIA FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS; 24/04/2018 – EXPRESS SCRIPTS ESRX.O SAYS PRESSING AMGEN INC AMGN.O , RIVALS TO CHANGE DYNAMIC OF HIGH LIST PRICES, DEEP REBATES ON NEW MIGRAINE MEDICINES; 16/03/2018 – Biotechnology Companies with Great Potential; 24/04/2018 – AMGEN 1Q ADJ. EPS $3.47, EST. $3.21; BOOSTS BOTTOM OF 2018 VIEW; 17/05/2018 – Novartis and Amgen Announce FDA Approval of Aimovig for Migraine Prevention; 27/04/2018 – Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis; 16/05/2018 – AMGEN: EC APPROVES REPATHA TO PREVENT HEART ATTACK, STROKE; 29/03/2018 – FDA: FDA granted accelerated approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients

Since January 16, 2018, it had 0 buys, and 6 selling transactions for $1.65 million activity.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, July 31. As per Tuesday, July 11, the company rating was reinitiated by Jefferies. The firm earned “Neutral” rating on Wednesday, January 24 by JP Morgan. The stock has “Hold” rating by Jefferies on Monday, June 12. The firm earned “Neutral” rating on Wednesday, September 28 by Citigroup. The firm has “Hold” rating by Argus Research given on Wednesday, November 1. Mizuho maintained Amgen Inc. (NASDAQ:AMGN) rating on Monday, February 12. Mizuho has “Buy” rating and $200.0 target. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Piper Jaffray on Thursday, October 12. Jefferies maintained Amgen Inc. (NASDAQ:AMGN) rating on Thursday, September 28. Jefferies has “Buy” rating and $200.0 target. The firm has “Buy” rating given on Monday, June 19 by Oppenheimer.

Founders Financial Securities Llc, which manages about $511.93 million and $309.24M US Long portfolio, decreased its stake in Bhp Billiton Ltd (NYSE:BHP) by 7,688 shares to 6,955 shares, valued at $309,000 in 2018Q1, according to the filing. It also reduced its holding in Vanguard Index Fds (VO) by 4,656 shares in the quarter, leaving it with 101,161 shares, and cut its stake in Vanguard Index Fds (VB).

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Better Buy: Amgen Inc. vs. Pfizer Inc.” on July 01, 2018, also Seekingalpha.com with their article: “Amgen Should Rebound On Aimovig And Kyprolis Revenue” published on June 20, 2018, Seekingalpha.com published: “EC grants full approval for Amgen’s Blincyto” on June 19, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Fool.com and their article: “3 Huge Biotech Winners in 2018 (So Far)” published on July 11, 2018 as well as Nasdaq.com‘s news article titled: “5 Cheap Large Cap Stocks to Buy Now” with publication date: June 28, 2018.

Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.34, from 1.22 in 2017Q4. It is negative, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Moreover, Cadence Capital Mngmt Llc has 0.84% invested in Amgen Inc. (NASDAQ:AMGN) for 75,914 shares. Arizona State Retirement Sys accumulated 173,818 shares or 0.3% of the stock. 7,100 are owned by Legg Mason Asset (Japan). Tirschwell & Loewy, a New York-based fund reported 77,024 shares. Dt Invest Limited Liability owns 0.04% invested in Amgen Inc. (NASDAQ:AMGN) for 1,449 shares. Tiedemann Advsr Limited Liability, New York-based fund reported 11,488 shares. Texas Permanent School Fund invested in 0.39% or 172,717 shares. Cypress Capital has invested 0.53% in Amgen Inc. (NASDAQ:AMGN). Miracle Mile Advsr Limited Liability, California-based fund reported 1,817 shares. Connable Office reported 0.48% in Amgen Inc. (NASDAQ:AMGN). Marco Inv Management Limited Liability Company holds 3% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 113,336 shares. Peddock Advisors Lc accumulated 67 shares. Pacific Heights Asset Management Lc holds 107,000 shares. Stifel Financial Corp has 0.28% invested in Amgen Inc. (NASDAQ:AMGN) for 526,251 shares. King Luther Mngmt reported 613,654 shares or 0.88% of all its holdings.

Since February 2, 2018, it had 1 insider buy, and 10 selling transactions for $27.85 million activity. HAGEDORN JAMES sold 18,877 shares worth $1.53 million. Hagedorn Partnership – L.P. also sold $2.96M worth of The Scotts Miracle-Gro Company (NYSE:SMG) shares. FINN BRIAN D bought $599,648 worth of stock or 7,500 shares. On Monday, May 14 Lukemire Michael C sold $701,646 worth of The Scotts Miracle-Gro Company (NYSE:SMG) or 8,594 shares. Johnson Stephen L also sold $130,103 worth of The Scotts Miracle-Gro Company (NYSE:SMG) on Friday, May 4.

More notable recent The Scotts Miracle-Gro Company (NYSE:SMG) news were published by: Fool.com which released: “Is It Time to Invest in Marijuana Stocks?” on July 11, 2018, also Globenewswire.com with their article: “Ortho and Pollinator Stewardship Council Help Home Gardeners “Bee Responsible”” published on June 27, 2018, Fool.com published: “Here’s Why The Scotts Miracle-Gro Company Fell 18.2% in 2018” on July 09, 2018. More interesting news about The Scotts Miracle-Gro Company (NYSE:SMG) were released by: Fool.com and their article: “3 Top Marijuana Stocks to Consider Buying for the Second Half of 2018” published on July 08, 2018 as well as Marketwatch.com‘s news article titled: “Scotts Miracle-Gro downgraded on headwind concerns” with publication date: June 20, 2018.

Investors sentiment increased to 1.19 in Q1 2018. Its up 0.11, from 1.08 in 2017Q4. It improved, as 34 investors sold SMG shares while 90 reduced holdings. 54 funds opened positions while 93 raised stakes. 35.26 million shares or 1.36% less from 35.74 million shares in 2017Q4 were reported. Baystate Wealth Mngmt Limited Co invested in 115 shares or 0% of the stock. Rwc Asset Management Ltd Liability Partnership holds 1.38% of its portfolio in The Scotts Miracle-Gro Company (NYSE:SMG) for 301,812 shares. Vantage Investment Advisors Ltd Liability accumulated 310 shares. Thomas White Limited has invested 0.06% in The Scotts Miracle-Gro Company (NYSE:SMG). Bb&T stated it has 0.08% of its portfolio in The Scotts Miracle-Gro Company (NYSE:SMG). Oregon Pub Employees Retirement Fund accumulated 15,420 shares. Sg Americas Securities Ltd Company invested in 9,500 shares. Paloma Prtn holds 0.02% or 13,920 shares. Aqr Limited Liability holds 0% or 2,552 shares in its portfolio. Aperio Limited Liability Company accumulated 23,577 shares or 0.01% of the stock. Private Tru Na owns 2,369 shares or 0.04% of their US portfolio. State Treasurer State Of Michigan accumulated 14,475 shares or 0.01% of the stock. Pinnacle Associates Limited reported 23,568 shares. Horizon Kinetics Ltd Llc holds 0.01% or 4,644 shares. Susquehanna Interest Limited Liability Partnership accumulated 145,431 shares.

Among 8 analysts covering Scotts Miracle-Gro Company (The) (NYSE:SMG), 2 have Buy rating, 4 Sell and 2 Hold. Therefore 25% are positive. Scotts Miracle-Gro Company (The) had 20 analyst reports since March 22, 2016 according to SRatingsIntel. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) has “Hold” rating given on Wednesday, November 8 by J.P. Morgan. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) has “Neutral” rating given on Wednesday, November 8 by JP Morgan. On Thursday, October 20 the stock rating was initiated by Gabelli with “Buy”. The company was downgraded on Friday, June 1 by J.P. Morgan. The firm earned “Hold” rating on Wednesday, January 11 by SunTrust. Bank of America downgraded The Scotts Miracle-Gro Company (NYSE:SMG) on Wednesday, May 2 to “Underperform” rating. As per Monday, October 16, the company rating was maintained by KeyBanc Capital Markets. The rating was maintained by KeyBanc Capital Markets with “Hold” on Monday, August 28. The firm earned “Buy” rating on Wednesday, November 8 by Bank of America. The rating was upgraded by Bank of America on Thursday, December 8 to “Buy”.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.